🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12219+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12219 recruiting trials

NARecruitingNCT06442592

Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

🏥 Nantes University Hospital📍 5 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06621199

Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML

🏥 First Affiliated Hospital of Zhejiang University📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06576505

Immunological Mechanisms in Sarcoidosis

👨‍⚕️ Susanna M Kullberg, MD, Karolinska University Hospital📍 1 site📅 Started Jul 2024View details ↗
Enrolling by InvitationNCT06744179

Post TB Sequelae Study

🏥 International Centre for Diarrhoeal Disease Research, Bangladesh📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06591169

Lifestyle Changes in PCOS with OSA and NAFLD

🏥 Cairo University📍 2 sites📅 Started Jul 2024View details ↗
NARecruitingNCT07285720

Phonological Constraints on Language Development in Individuals With Williams Syndrome

🏥 Centre Hospitalier Universitaire, Amiens📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06590948

Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Jul 2024View details ↗
Phase 1RecruitingNCT06818838

A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease

👨‍⚕️ Fengkui Zhang, PhD, Hematology Hospital, Chinese Academy of Medical Sciences📍 3 sites📅 Started Jul 2024View details ↗
Phase 1Enrolling by InvitationNCT06782958

Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults

👨‍⚕️ Ting Wang, LanZhou University📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT07143201

Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT

👨‍⚕️ Samira Samiee-Zafarghandy, MD, FRCPC, McMaster University📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06528197

Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine

🏥 China-Japan Friendship Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06093061

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

👨‍⚕️ Melvin LK CHUA, MBBS, FRCR, PhD, FAMS, National Cancer Centre, Singapore📍 2 sites📅 Started Jul 2024View details ↗
Phase 1, PHASE2RecruitingNCT05932199

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

👨‍⚕️ Robert Ripley, MD, Baylor College of Medicine📍 2 sites📅 Started Jul 2024View details ↗
NARecruitingNCT06453018

Positional Therapy for Childhood Obstructive Sleep Apnoea

👨‍⚕️ Kate Ching Ching Chan, MD, Chinese University of Hong Kong📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06716398

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

🏥 Pierre Fabre Dermo Cosmetique📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06339177

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

👨‍⚕️ Joseph M Rocco, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 2 sites📅 Started Jul 2024View details ↗
Phase 1RecruitingNCT06569472

Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

👨‍⚕️ Meiping Lu, M.D, Children's Hospital, Zhejiang University School of Medicine📍 1 site📅 Started Jul 2024View details ↗
Phase 1, PHASE2RecruitingNCT06328777

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

👨‍⚕️ Medical Director, Cabaletta Bio📍 10 sites📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06483906

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

👨‍⚕️ Xianmin Song, MD, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jul 2024View details ↗
RecruitingNCT06343051

USCOM in Newly Diagnosed FGR Cases

👨‍⚕️ Nicola F Tavella, MPH, Icahn School of Medicine at Mount Sinai📍 1 site📅 Started Jul 2024View details ↗
← PreviousPage 272 of 611Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →